Healthcare/Biotech

WHO's decision on Bharat Biotech's Covaxin in October

​Decision in October
Reuters
1/5
​Decision in October
Bharat Biotech has applied for emergency use listing (EUL) for its Covaxin COVID-19 vaccine. The World Health Organisation has said the decision will be made in October.
​Date on WHO website
AFP
2/5
​Date on WHO website
The latest ‘Status of COVID-19 vaccines within WHO EUL/PQ evaluation process' guidance document on the WHO website said the decision date is “October 2021”.
​Assessment 'ongoing'
BCCL
3/5
​Assessment 'ongoing'
Bharat Biotech had submitted EOI (Expression of Interest) on April 19 for its vaccine. The status of assessment says “ongoing”.
​Submissions confidential
AFP
4/5
​Submissions confidential
Submissions to WHO for prequalification or listing under the emergency use procedure are confidential. If assessment is found to meet the criteria, the global agency will publish the results widely.
​Widely used in India
AP
5/5
​Widely used in India
Bharat Biotech's Covaxin and AstraZeneca and Oxford University's Covishield are the two widely used vaccines in India. The latter has a WHO listing.
Open in App
Success
This article has been saved